Harold L. Kohn,Christophe Salomé,Elise Salomé-Grosjean
申请号：
US13395588
公开号：
US20120232015A1
申请日:
2010.09.17
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A first aspect of the invention is a compound (sometimes also referred to herein as an “active agent” or “active compound”) of Formula Ia, or more particularly Formula Ib, or a pharmaceutically acceptable salt or prodrug thereof. Compositions thereof and methods of using the same (e.g. for the treatment of a neurological disease) are also described.
